{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T15:12:35Z","timestamp":1774019555999,"version":"3.50.1"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T00:00:00Z","timestamp":1611014400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"DOI":"10.13039\/501100001871","name":"Funda\u00e7\u00e3o para a Ci\u00eancia e a Tecnologia","doi-asserted-by":"publisher","award":["UID\/BIM\/04293\/2013"],"award-info":[{"award-number":["UID\/BIM\/04293\/2013"]}],"id":[{"id":"10.13039\/501100001871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cancer Chemother Pharmacol"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s00280-020-04218-6","type":"journal-article","created":{"date-parts":[[2021,1,19]],"date-time":"2021-01-19T11:04:56Z","timestamp":1611054296000},"page":"447-464","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["The role of the glutamine transporter ASCT2 in antineoplastic therapy"],"prefix":"10.1007","volume":"87","author":[{"given":"Estef\u00e2nia","family":"Teixeira","sequence":"first","affiliation":[]},{"given":"Cl\u00e1udia","family":"Silva","sequence":"additional","affiliation":[]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0525-3416","authenticated-orcid":false,"given":"F\u00e1tima","family":"Martel","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2021,1,19]]},"reference":[{"issue":"5","key":"4218_CR1","doi-asserted-by":"publisher","first-page":"e1600200","DOI":"10.1126\/sciadv.1600200","volume":"2","author":"RJ DeBerardinis","year":"2016","unstructured":"DeBerardinis RJ, Chandel NS (2016) Fundamentals of cancer metabolism. Sci Adv 2(5):e1600200. https:\/\/doi.org\/10.1126\/sciadv.1600200","journal-title":"Sci Adv"},{"issue":"4","key":"4218_CR2","doi-asserted-by":"publisher","first-page":"657","DOI":"10.1016\/j.cell.2016.12.039","volume":"168","author":"MG Vander Heiden","year":"2017","unstructured":"Vander Heiden MG, DeBerardinis RJ (2017) Understanding the intersections between metabolism and cancer biology. Cell 168(4):657\u2013669. https:\/\/doi.org\/10.1016\/j.cell.2016.12.039","journal-title":"Cell"},{"issue":"1","key":"4218_CR3","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1038\/s41416-019-0637-9","volume":"122","author":"Z Zhang","year":"2020","unstructured":"Zhang Z, Liu R, Shuai Y, Huang Y, Jin R, Wang X, Luo J (2020) ASCT2 (SLC1A5)-dependent glutamine uptake is involved in the progression of head and neck squamous cell carcinoma. Br J Cancer 122(1):82\u201393. https:\/\/doi.org\/10.1038\/s41416-019-0637-9","journal-title":"Br J Cancer"},{"issue":"11","key":"4218_CR4","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1038\/nrc.2016.114","volume":"16","author":"BJ Altman","year":"2016","unstructured":"Altman BJ, Stine ZE, Dang CV (2016) From Krebs to clinic: glutamine metabolism to cancer therapy. Nat Rev Cancer 16(11):749. https:\/\/doi.org\/10.1038\/nrc.2016.114","journal-title":"Nat Rev Cancer"},{"issue":"9","key":"4218_CR5","doi-asserted-by":"publisher","first-page":"3678","DOI":"10.1172\/JCI69600","volume":"123","author":"CT Hensley","year":"2013","unstructured":"Hensley CT, Wasti AT, DeBerardinis RJ (2013) Glutamine and cancer: cell biology, physiology, and clinical opportunities. J Clin Invest 123(9):3678\u20133684. https:\/\/doi.org\/10.1172\/JCI69600","journal-title":"J Clin Invest"},{"issue":"8","key":"4218_CR6","doi-asserted-by":"publisher","first-page":"1198","DOI":"10.1080\/15548627.2015.1053680","volume":"11","author":"VH Villar","year":"2015","unstructured":"Villar VH, Merhi F, Djavaheri-Mergny M, Duran RV (2015) Glutaminolysis and autophagy in cancer. Autophagy 11(8):1198\u20131208. https:\/\/doi.org\/10.1080\/15548627.2015.1053680","journal-title":"Autophagy"},{"issue":"9","key":"4218_CR7","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1158\/0008-5472.CAN-14-3745","volume":"75","author":"YD Bhutia","year":"2015","unstructured":"Bhutia YD, Babu E, Ramachandran S, Ganapathy V (2015) Amino acid transporters in cancer and their relevance to \u201cglutamine addiction\u201d: novel targets for the design of a new class of anticancer drugs. Cancer Res 75(9):1782\u20131788. https:\/\/doi.org\/10.1158\/0008-5472.CAN-14-3745","journal-title":"Cancer Res"},{"key":"4218_CR8","doi-asserted-by":"publisher","DOI":"10.1007\/s11064-019-02934-x","author":"N Freidman","year":"2020","unstructured":"Freidman N, Chen I, Wu Q, Briot C, Holst J, Font J, Vandenberg R, Ryan R (2020) Amino acid transporters and exchangers from the SLC1A family: structure, mechanism and roles in physiology and cancer. Neurochem Res. https:\/\/doi.org\/10.1007\/s11064-019-02934-x","journal-title":"Neurochem Res"},{"issue":"1","key":"4218_CR9","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1002\/cam4.2689","volume":"9","author":"Y Hara","year":"2020","unstructured":"Hara Y, Minami Y, Yoshimoto S, Hayashi N, Yamasaki A, Ueda S, Masuko K, Masuko T (2020) Anti-tumor effects of an antagonistic mAb against the ASCT2 amino acid transporter on KRAS-mutated human colorectal cancer cells. Cancer Med 9(1):302\u2013312. https:\/\/doi.org\/10.1002\/cam4.2689","journal-title":"Cancer Med"},{"issue":"9","key":"4218_CR10","doi-asserted-by":"publisher","first-page":"474","DOI":"10.5483\/BMBRep.2018.51.9.114","volume":"51","author":"Z Liu","year":"2018","unstructured":"Liu Z, Peng Q, Li Y, Gao Y (2018) Resveratrol enhances cisplatin-induced apoptosis in human hepatoma cells via glutamine metabolism inhibition. BMB Rep 51(9):474\u2013479","journal-title":"BMB Rep"},{"issue":"3","key":"4218_CR11","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s42255-019-0039-6","volume":"1","author":"F Ni","year":"2019","unstructured":"Ni F, Yu WM, Li Z, Graham DK, Jin L, Kang S, Rossi MR, Li S, Broxmeyer HE, Qu CK (2019) Critical role of ASCT2-mediated amino acid metabolism in promoting leukaemia development and progression. Nat Metab 1(3):390\u2013403. https:\/\/doi.org\/10.1038\/s42255-019-0039-6","journal-title":"Nat Metab"},{"issue":"8","key":"4218_CR12","first-page":"1499","volume":"8","author":"A Osanai-Sasakawa","year":"2018","unstructured":"Osanai-Sasakawa A, Hosomi K, Sumitomo Y, Takizawa T, Tomura-Suruki S, Imaizumi M, Kasai N, Poh TW, Yamano K, Yong WP, Kono K, Nakamura S, Ishii T, Nakai R (2018) An anti-ASCT2 monoclonal antibody suppresses gastric cancer growth by inducing oxidative stress and antibody dependent cellular toxicity in preclinical models. Am J Cancer Res 8(8):1499\u20131513","journal-title":"Am J Cancer Res"},{"issue":"4","key":"4218_CR13","doi-asserted-by":"publisher","first-page":"651","DOI":"10.1016\/j.bbrc.2016.11.089","volume":"482","author":"M Suzuki","year":"2017","unstructured":"Suzuki M, Toki H, Furuya A, Ando H (2017) Establishment of monoclonal antibodies against cell surface domains of ASCT2\/SLC1A5 and their inhibition of glutamine-dependent tumor cell growth. Biochem Biophys Res Commun 482(4):651\u2013657. https:\/\/doi.org\/10.1016\/j.bbrc.2016.11.089","journal-title":"Biochem Biophys Res Commun"},{"key":"4218_CR14","first-page":"1","volume":"10","author":"CR Scriver","year":"1973","unstructured":"Scriver CR, Rosenberg LE (1973) Amino acid metabolism and its disorders. Major Probl Clin Pediatr 10:1\u2013478","journal-title":"Major Probl Clin Pediatr"},{"key":"4218_CR15","doi-asserted-by":"publisher","first-page":"126","DOI":"10.20517\/cdr.2018.08","volume":"1","author":"T-L Nguyen","year":"2018","unstructured":"Nguyen T-L, Dur\u00e1n RV (2018) Glutamine metabolism in cancer therapy. Cancer Drug Resist 1:126\u2013138. https:\/\/doi.org\/10.20517\/cdr.2018.08","journal-title":"Cancer Drug Resist"},{"issue":"4","key":"4218_CR16","doi-asserted-by":"publisher","first-page":"514","DOI":"10.1016\/j.molcel.2015.10.018","volume":"60","author":"GM DeNicola","year":"2015","unstructured":"DeNicola GM, Cantley LC (2015) Cancer\u2019s fuel choice: new flavors for a picky eater. Mol Cell 60(4):514\u2013523. https:\/\/doi.org\/10.1016\/j.molcel.2015.10.018","journal-title":"Mol Cell"},{"issue":"1","key":"4218_CR17","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cmet.2015.12.006","volume":"23","author":"NN Pavlova","year":"2016","unstructured":"Pavlova NN, Thompson CB (2016) The emerging hallmarks of cancer metabolism. Cell Metab 23(1):27\u201347. https:\/\/doi.org\/10.1016\/j.cmet.2015.12.006","journal-title":"Cell Metab"},{"issue":"11","key":"4218_CR18","doi-asserted-by":"publisher","first-page":"1375","DOI":"10.1038\/bjc.2017.113","volume":"116","author":"ER Still","year":"2017","unstructured":"Still ER, Yuneva MO (2017) Hopefully devoted to Q: targeting glutamine addiction in cancer. Br J Cancer 116(11):1375\u20131381. https:\/\/doi.org\/10.1038\/bjc.2017.113","journal-title":"Br J Cancer"},{"key":"4218_CR19","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.semcdb.2019.05.012","volume":"98","author":"JM Mates","year":"2020","unstructured":"Mates JM, Di Paola FJ, Campos-Sandoval JA, Mazurek S, Marquez J (2020) Therapeutic targeting of glutaminolysis as an essential strategy to combat cancer. Semin Cell Dev Biol 98:34\u201343. https:\/\/doi.org\/10.1016\/j.semcdb.2019.05.012","journal-title":"Semin Cell Dev Biol"},{"issue":"1","key":"4218_CR20","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12957-016-0769-9","volume":"14","author":"C Li","year":"2016","unstructured":"Li C, Zhang G, Zhao L, Ma Z, Chen H (2016) Metabolic reprogramming in cancer cells: glycolysis, glutaminolysis, and Bcl-2 proteins as novel therapeutic targets for cancer. World J Surg Oncol 14(1):15. https:\/\/doi.org\/10.1186\/s12957-016-0769-9","journal-title":"World J Surg Oncol"},{"key":"4218_CR21","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1016\/j.bbcan.2012.06.004","volume":"2","author":"JQ Chen","year":"1826","unstructured":"Chen JQ (1826) Russo J (2012) Dysregulation of glucose transport, glycolysis, TCA cycle and glutaminolysis by oncogenes and tumor suppressors in cancer cells. Biochim Biophys Acta 2:370\u2013384. https:\/\/doi.org\/10.1016\/j.bbcan.2012.06.004","journal-title":"Biochim Biophys Acta"},{"issue":"4","key":"4218_CR22","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1093\/nar\/gkv047","volume":"43","author":"AN Lane","year":"2015","unstructured":"Lane AN, Fan TW (2015) Regulation of mammalian nucleotide metabolism and biosynthesis. Nucleic Acids Res 43(4):2466\u20132485. https:\/\/doi.org\/10.1093\/nar\/gkv047","journal-title":"Nucleic Acids Res"},{"issue":"3","key":"4218_CR23","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/j.ccr.2010.08.009","volume":"18","author":"JB Wang","year":"2010","unstructured":"Wang JB, Erickson JW, Fuji R, Ramachandran S, Gao P, Dinavahi R, Wilson KF, Ambrosio AL, Dias SM, Dang CV, Cerione RA (2010) Targeting mitochondrial glutaminase activity inhibits oncogenic transformation. Cancer Cell 18(3):207\u2013219. https:\/\/doi.org\/10.1016\/j.ccr.2010.08.009","journal-title":"Cancer Cell"},{"issue":"21","key":"4218_CR24","doi-asserted-by":"publisher","first-page":"8674","DOI":"10.1073\/pnas.1016627108","volume":"108","author":"T Cheng","year":"2011","unstructured":"Cheng T, Sudderth J, Yang C, Mullen AR, Jin ES, Mates JM, DeBerardinis RJ (2011) Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci USA 108(21):8674\u20138679. https:\/\/doi.org\/10.1073\/pnas.1016627108","journal-title":"Proc Natl Acad Sci USA"},{"key":"4218_CR25","unstructured":"CALITHERA (2020) Glutaminase Inhibitor Telaglenastat (CB-839). https:\/\/www.calithera.com\/glutaminase-inhibitor-cb-839\/. Accessed 19 Nov 2020"},{"issue":"2","key":"4218_CR26","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s00109-015-1307-x","volume":"94","author":"I Marchiq","year":"2016","unstructured":"Marchiq I, Pouyssegur J (2016) Hypoxia, cancer metabolism and the therapeutic benefit of targeting lactate\/H(+) symporters. J Mol Med (Berl) 94(2):155\u2013171. https:\/\/doi.org\/10.1007\/s00109-015-1307-x","journal-title":"J Mol Med (Berl)"},{"issue":"49","key":"4218_CR27","doi-asserted-by":"publisher","first-page":"19345","DOI":"10.1073\/pnas.0709747104","volume":"104","author":"RJ DeBerardinis","year":"2007","unstructured":"DeBerardinis RJ, Mancuso A, Daikhin E, Nissim I, Yudkoff M, Wehrli S, Thompson CB (2007) Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A 104(49):19345\u201319350. https:\/\/doi.org\/10.1073\/pnas.0709747104","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"3","key":"4218_CR28","doi-asserted-by":"publisher","first-page":"313","DOI":"10.1038\/onc.2009.358","volume":"29","author":"RJ DeBerardinis","year":"2010","unstructured":"DeBerardinis RJ, Cheng T (2010) Q\u2019s next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene 29(3):313\u2013324. https:\/\/doi.org\/10.1038\/onc.2009.358","journal-title":"Oncogene"},{"issue":"4","key":"4218_CR29","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1016\/j.semcdb.2012.02.002","volume":"23","author":"D Daye","year":"2012","unstructured":"Daye D, Wellen KE (2012) Metabolic reprogramming in cancer: unraveling the role of glutamine in tumorigenesis. Semin Cell Dev Biol 23(4):362\u2013369. https:\/\/doi.org\/10.1016\/j.semcdb.2012.02.002","journal-title":"Semin Cell Dev Biol"},{"issue":"10","key":"4218_CR30","doi-asserted-by":"publisher","first-page":"1302","DOI":"10.15252\/embj.201696151","volume":"36","author":"J Zhang","year":"2017","unstructured":"Zhang J, Pavlova NN, Thompson CB (2017) Cancer cell metabolism: the essential role of the nonessential amino acid, glutamine. EMBO J 36(10):1302\u20131315. https:\/\/doi.org\/10.15252\/embj.201696151","journal-title":"EMBO J"},{"issue":"28","key":"4218_CR31","doi-asserted-by":"publisher","first-page":"3619","DOI":"10.1038\/onc.2015.447","volume":"35","author":"L Jin","year":"2016","unstructured":"Jin L, Alesi GN, Kang S (2016) Glutaminolysis as a target for cancer therapy. Oncogene 35(28):3619\u20133625. https:\/\/doi.org\/10.1038\/onc.2015.447","journal-title":"Oncogene"},{"issue":"1","key":"4218_CR32","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1152\/physrev.1990.70.1.43","volume":"70","author":"HN Christensen","year":"1990","unstructured":"Christensen HN (1990) Role of amino acid transport and countertransport in nutrition and metabolism. Physiol Rev 70(1):43\u201377. https:\/\/doi.org\/10.1152\/physrev.1990.70.1.43","journal-title":"Physiol Rev"},{"issue":"2","key":"4218_CR33","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1007\/s00424-015-1742-0","volume":"468","author":"K Chan","year":"2016","unstructured":"Chan K, Busque SM, Sailer M, Stoeger C, Broer S, Daniel H, Rubio-Aliaga I, Wagner CA (2016) Loss of function mutation of the Slc38a3 glutamine transporter reveals its critical role for amino acid metabolism in the liver, brain, and kidney. Pflugers Arch 468(2):213\u2013227. https:\/\/doi.org\/10.1007\/s00424-015-1742-0","journal-title":"Pflugers Arch"},{"key":"4218_CR34","doi-asserted-by":"publisher","first-page":"1460","DOI":"10.1016\/j.bbamem.2018.04.005","volume":"7","author":"Y Ge","year":"1860","unstructured":"Ge Y, Gu Y, Wang J (1860) Zhang Z (2018) Membrane topology of rat sodium-coupled neutral amino acid transporter 2 (SNAT2). Biochim Biophys Acta Biomembr 7:1460\u20131469. https:\/\/doi.org\/10.1016\/j.bbamem.2018.04.005","journal-title":"Biochim Biophys Acta Biomembr"},{"issue":"7","key":"4218_CR35","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1073\/pnas.050318197","volume":"97","author":"S Gu","year":"2000","unstructured":"Gu S, Roderick HL, Camacho P, Jiang JX (2000) Identification and characterization of an amino acid transporter expressed differentially in liver. Proc Natl Acad Sci USA 97(7):3230\u20133235. https:\/\/doi.org\/10.1073\/pnas.050318197","journal-title":"Proc Natl Acad Sci USA"},{"key":"4218_CR36","doi-asserted-by":"publisher","first-page":"371","DOI":"10.2741\/2070","volume":"12","author":"D Haussinger","year":"2007","unstructured":"Haussinger D, Schliess F (2007) Glutamine metabolism and signaling in the liver. Front Biosci 12:371\u2013391. https:\/\/doi.org\/10.2741\/2070","journal-title":"Front Biosci"},{"issue":"6","key":"4218_CR37","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1002\/glia.23133","volume":"65","author":"AC Todd","year":"2017","unstructured":"Todd AC, Marx MC, Hulme SR, Broer S, Billups B (2017) SNAT3-mediated glutamine transport in perisynaptic astrocytes in situ is regulated by intracellular sodium. Glia 65(6):900\u2013916. https:\/\/doi.org\/10.1002\/glia.23133","journal-title":"Glia"},{"issue":"2","key":"4218_CR38","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/s0165-3806(03)00107-x","volume":"143","author":"MD Weiss","year":"2003","unstructured":"Weiss MD, Derazi S, Rossignol C, Varoqui H, Erickson JD, Kilberg MS, Anderson KJ (2003) Ontogeny of the neutral amino acid transporter SAT1\/ATA1 in rat brain. Brain Res Dev Brain Res 143(2):151\u2013159. https:\/\/doi.org\/10.1016\/s0165-3806(03)00107-x","journal-title":"Brain Res Dev Brain Res"},{"issue":"5","key":"4218_CR39","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1681\/ASN.2006091014","volume":"18","author":"K Evans","year":"2007","unstructured":"Evans K, Nasim Z, Brown J, Butler H, Kauser S, Varoqui H, Erickson JD, Herbert TP, Bevington A (2007) Acidosis-sensing glutamine pump SNAT2 determines amino acid levels and mammalian target of rapamycin signalling to protein synthesis in L6 muscle cells. J Am Soc Nephrol 18(5):1426\u20131436. https:\/\/doi.org\/10.1681\/ASN.2006091014","journal-title":"J Am Soc Nephrol"},{"key":"4218_CR40","doi-asserted-by":"publisher","first-page":"1289","DOI":"10.2741\/e332","volume":"3","author":"J Pinilla","year":"2011","unstructured":"Pinilla J, Aledo JC, Cwiklinski E, Hyde R, Taylor PM, Hundal HS (2011) SNAT2 transceptor signalling via mTOR: a role in cell growth and proliferation? Front Biosci (Elite Ed) 3:1289\u20131299. https:\/\/doi.org\/10.2741\/e332","journal-title":"Front Biosci (Elite Ed)"},{"issue":"31","key":"4218_CR41","doi-asserted-by":"publisher","first-page":"18657","DOI":"10.1074\/jbc.271.31.18657","volume":"271","author":"R Kekuda","year":"1996","unstructured":"Kekuda R, Prasad PD, Fei YJ, Torres-Zamorano V, Sinha S, Yang-Feng TL, Leibach FH, Ganapathy V (1996) Cloning of the sodium-dependent, broad-scope, neutral amino acid transporter Bo from a human placental choriocarcinoma cell line. J Biol Chem 271(31):18657\u201318661. https:\/\/doi.org\/10.1074\/jbc.271.31.18657","journal-title":"J Biol Chem"},{"issue":"4","key":"4218_CR42","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1016\/j.semcancer.2005.04.005","volume":"15","author":"BC Fuchs","year":"2005","unstructured":"Fuchs BC, Bode BP (2005) Amino acid transporters ASCT2 and LAT1 in cancer: partners in crime? Semin Cancer Biol 15(4):254\u2013266. https:\/\/doi.org\/10.1016\/j.semcancer.2005.04.005","journal-title":"Semin Cancer Biol"},{"issue":"Pt 3","key":"4218_CR43","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1042\/bj3460705","volume":"346","author":"A Broer","year":"2000","unstructured":"Broer A, Wagner C, Lang F, Broer S (2000) Neutral amino acid transporter ASCT2 displays substrate-induced Na+ exchange and a substrate-gated anion conductance. Biochem J 346(Pt 3):705\u2013710","journal-title":"Biochem J"},{"key":"4218_CR44","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19030907","author":"YJ Cha","year":"2018","unstructured":"Cha YJ, Kim ES, Koo JS (2018) Amino acid transporters and glutamine metabolism in breast cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19030907","journal-title":"Int J Mol Sci"},{"issue":"44","key":"4218_CR45","doi-asserted-by":"publisher","first-page":"76458","DOI":"10.18632\/oncotarget.19479","volume":"8","author":"J Lu","year":"2017","unstructured":"Lu J, Chen M, Tao Z, Gao S, Li Y, Cao Y, Lu C, Zou X (2017) Effects of targeting SLC1A5 on inhibiting gastric cancer growth and tumor development in vitro and in vivo. Oncotarget 8(44):76458\u201376467. https:\/\/doi.org\/10.18632\/oncotarget.19479","journal-title":"Oncotarget"},{"issue":"7","key":"4218_CR46","doi-asserted-by":"publisher","first-page":"e367","DOI":"10.1038\/oncsis.2017.70","volume":"6","author":"AD Marshall","year":"2017","unstructured":"Marshall AD, van Geldermalsen M, Otte NJ, Lum T, Vellozzi M, Thoeng A, Pang A, Nagarajah R, Zhang B, Wang Q, Anderson L, Rasko JEJ, Holst J (2017) ASCT2 regulates glutamine uptake and cell growth in endometrial carcinoma. Oncogenesis 6(7):e367. https:\/\/doi.org\/10.1038\/oncsis.2017.70","journal-title":"Oncogenesis"},{"issue":"2","key":"4218_CR47","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1038\/nm.4464","volume":"24","author":"ML Schulte","year":"2018","unstructured":"Schulte ML, Fu A, Zhao P, Li J, Geng L, Smith ST, Kondo J, Coffey RJ, Johnson MO, Rathmell JC, Sharick JT, Skala MC, Smith JA, Berlin J, Washington MK, Nickels ML, Manning HC (2018) Pharmacological blockade of ASCT2-dependent glutamine transport leads to antitumor efficacy in preclinical models. Nat Med 24(2):194\u2013202. https:\/\/doi.org\/10.1038\/nm.4464","journal-title":"Nat Med"},{"issue":"5","key":"4218_CR48","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1002\/ijc.28749","volume":"135","author":"Q Wang","year":"2014","unstructured":"Wang Q, Beaumont KA, Otte NJ, Font J, Bailey CG, van Geldermalsen M, Sharp DM, Tiffen JC, Ryan RM, Jormakka M, Haass NK, Rasko JE, Holst J (2014) Targeting glutamine transport to suppress melanoma cell growth. Int J Cancer 135(5):1060\u20131071. https:\/\/doi.org\/10.1002\/ijc.28749","journal-title":"Int J Cancer"},{"issue":"3","key":"4218_CR49","doi-asserted-by":"publisher","first-page":"278","DOI":"10.1002\/path.4518","volume":"236","author":"Q Wang","year":"2015","unstructured":"Wang Q, Hardie RA, Hoy AJ, van Geldermalsen M, Gao D, Fazli L, Sadowski MC, Balaban S, Schreuder M, Nagarajah R, Wong JJ, Metierre C, Pinello N, Otte NJ, Lehman ML, Gleave M, Nelson CC, Bailey CG, Ritchie W, Rasko JE, Holst J (2015) Targeting ASCT2-mediated glutamine uptake blocks prostate cancer growth and tumour development. J Pathol 236(3):278\u2013289. https:\/\/doi.org\/10.1002\/path.4518","journal-title":"J Pathol"},{"key":"4218_CR50","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biocel.2015.08.004","volume":"67","author":"L Napolitano","year":"2015","unstructured":"Napolitano L, Scalise M, Galluccio M, Pochini L, Albanese LM, Indiveri C (2015) LAT1 is the transport competent unit of the LAT1\/CD98 heterodimeric amino acid transporter. Int J Biochem Cell Biol 67:25\u201333. https:\/\/doi.org\/10.1016\/j.biocel.2015.08.004","journal-title":"Int J Biochem Cell Biol"},{"issue":"6218","key":"4218_CR51","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1126\/science.1259472","volume":"347","author":"JL Jewell","year":"2015","unstructured":"Jewell JL, Kim YC, Russell RC, Yu FX, Park HW, Plouffe SW, Tagliabracci VS, Guan KL (2015) Metabolism. Differential regulation of mTORC1 by leucine and glutamine. Science 347(6218):194\u2013198. https:\/\/doi.org\/10.1126\/science.1259472","journal-title":"Science"},{"issue":"43","key":"4218_CR52","doi-asserted-by":"publisher","first-page":"31444","DOI":"10.1074\/jbc.M704524200","volume":"282","author":"J Fort","year":"2007","unstructured":"Fort J, de la Ballina LR, Burghardt HE, Ferrer-Costa C, Turnay J, Ferrer-Orta C, Uson I, Zorzano A, Fernandez-Recio J, Orozco M, Lizarbe MA, Fita I, Palacin M (2007) The structure of human 4F2hc ectodomain provides a model for homodimerization and electrostatic interaction with plasma membrane. J Biol Chem 282(43):31444\u201331452. https:\/\/doi.org\/10.1074\/jbc.M704524200","journal-title":"J Biol Chem"},{"issue":"4","key":"4218_CR53","doi-asserted-by":"publisher","first-page":"C1077","DOI":"10.1152\/ajpcell.2001.281.4.C1077","volume":"281","author":"CA Wagner","year":"2001","unstructured":"Wagner CA, Lang F, Broer S (2001) Function and structure of heterodimeric amino acid transporters. Am J Physiol Cell Physiol 281(4):C1077-1093. https:\/\/doi.org\/10.1152\/ajpcell.2001.281.4.C1077","journal-title":"Am J Physiol Cell Physiol"},{"key":"4218_CR54","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19082373","author":"TB Salisbury","year":"2018","unstructured":"Salisbury TB, Arthur S (2018) The regulation and function of the L-type amino acid transporter 1 (LAT1) in cancer. Int J Mol Sci. https:\/\/doi.org\/10.3390\/ijms19082373","journal-title":"Int J Mol Sci"},{"issue":"1","key":"4218_CR55","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s10549-018-05111-w","volume":"175","author":"R El-Ansari","year":"2019","unstructured":"El-Ansari R, Craze ML, Alfarsi L, Soria D, Diez-Rodriguez M, Nolan CC, Ellis IO, Rakha EA, Green AR (2019) The combined expression of solute carriers is associated with a poor prognosis in highly proliferative ER+ breast cancer. Breast Cancer Res Treat 175(1):27\u201338. https:\/\/doi.org\/10.1007\/s10549-018-05111-w","journal-title":"Breast Cancer Res Treat"},{"issue":"36","key":"4218_CR56","doi-asserted-by":"publisher","first-page":"31830","DOI":"10.1074\/jbc.M111.229518","volume":"286","author":"S Karunakaran","year":"2011","unstructured":"Karunakaran S, Ramachandran S, Coothankandaswamy V, Elangovan S, Babu E, Periyasamy-Thandavan S, Gurav A, Gnanaprakasam JP, Singh N, Schoenlein PV, Prasad PD, Thangaraju M, Ganapathy V (2011) SLC6A14 (ATB0,+) protein, a highly concentrative and broad specific amino acid transporter, is a novel and effective drug target for treatment of estrogen receptor-positive breast cancer. J Biol Chem 286(36):31830\u201331838. https:\/\/doi.org\/10.1074\/jbc.M111.229518","journal-title":"J Biol Chem"},{"issue":"4","key":"4218_CR57","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.7150\/thno.18005","volume":"7","author":"Y Jiang","year":"2017","unstructured":"Jiang Y, Cao Y, Wang Y, Li W, Liu X, Lv Y, Li X, Mi J (2017) Cysteine transporter SLC3A1 promotes breast cancer tumorigenesis. Theranostics 7(4):1036\u20131046. https:\/\/doi.org\/10.7150\/thno.18005","journal-title":"Theranostics"},{"issue":"4","key":"4218_CR58","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1002\/ijc.21186","volume":"117","author":"JC Leo","year":"2005","unstructured":"Leo JC, Wang SM, Guo CH, Aw SE, Zhao Y, Li JM, Hui KM, Lin VC (2005) Gene regulation profile reveals consistent anticancer properties of progesterone in hormone-independent breast cancer cells transfected with progesterone receptor. Int J Cancer 117(4):561\u2013568. https:\/\/doi.org\/10.1002\/ijc.21186","journal-title":"Int J Cancer"},{"issue":"11","key":"4218_CR59","doi-asserted-by":"publisher","first-page":"1101","DOI":"10.4161\/cbt.10.11.13444","volume":"10","author":"R Sweet","year":"2010","unstructured":"Sweet R, Paul A, Zastre J (2010) Hypoxia induced upregulation and function of the thiamine transporter, SLC19A3 in a breast cancer cell line. Cancer Biol Ther 10(11):1101\u20131111. https:\/\/doi.org\/10.4161\/cbt.10.11.13444","journal-title":"Cancer Biol Ther"},{"key":"4218_CR60","doi-asserted-by":"publisher","first-page":"103","DOI":"10.4137\/BMI.S30559","volume":"10","author":"A Thakkar","year":"2015","unstructured":"Thakkar A, Raj H, Ravishankar MB, Balakrishnan A, Padigaru M (2015) High expression of three-gene signature improves prediction of relapse-free survival in estrogen receptor-positive and node-positive breast tumors. Biomark Insights 10:103\u2013112. https:\/\/doi.org\/10.4137\/BMI.S30559","journal-title":"Biomark Insights"},{"issue":"4","key":"4218_CR61","doi-asserted-by":"publisher","first-page":"450","DOI":"10.1016\/j.ccr.2013.08.020","volume":"24","author":"LA Timmerman","year":"2013","unstructured":"Timmerman LA, Holton T, Yuneva M, Louie RJ, Padro M, Daemen A, Hu M, Chan DA, Ethier SP, Van \u2019t Veer LJ, Polyak K, McCormick F, Gray JW (2013) Glutamine sensitivity analysis identifies the xCT antiporter as a common triple-negative breast tumor therapeutic target. Cancer Cell 24(4):450\u2013465. https:\/\/doi.org\/10.1016\/j.ccr.2013.08.020","journal-title":"Cancer Cell"},{"key":"4218_CR62","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1186\/1471-2407-13-343","volume":"13","author":"K Wang","year":"2013","unstructured":"Wang K, Cao F, Fang W, Hu Y, Chen Y, Ding H, Yu G (2013) Activation of SNAT1\/SLC38A1 in human breast cancer: correlation with p-Akt overexpression. BMC Cancer 13:343. https:\/\/doi.org\/10.1186\/1471-2407-13-343","journal-title":"BMC Cancer"},{"key":"4218_CR63","doi-asserted-by":"publisher","DOI":"10.3390\/metabo9030050","author":"LD Rajasinghe","year":"2019","unstructured":"Rajasinghe LD, Hutchings M, Gupta SV (2019) Delta-tocotrienol modulates glutamine dependence by inhibiting ASCT2 and LAT1 transporters in non-small cell lung cancer (NSCLC) cells: a metabolomic approach. Metabolites. https:\/\/doi.org\/10.3390\/metabo9030050","journal-title":"Metabolites"},{"key":"4218_CR64","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.phymed.2018.12.011","volume":"57","author":"L Wang","year":"2019","unstructured":"Wang L, Liu Y, Zhao TL, Li ZZ, He JY, Zhang BJ, Du HZ, Jiang JW, Yuan ST, Sun L (2019) Topotecan induces apoptosis via ASCT2 mediated oxidative stress in gastric cancer. Phytomedicine 57:117\u2013128. https:\/\/doi.org\/10.1016\/j.phymed.2018.12.011","journal-title":"Phytomedicine"},{"issue":"Pt 1","key":"4218_CR65","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1042\/BJ20040487","volume":"382","author":"CI Bungard","year":"2004","unstructured":"Bungard CI, McGivan JD (2004) Glutamine availability up-regulates expression of the amino acid transporter protein ASCT2 in HepG2 cells and stimulates the ASCT2 promoter. Biochem J 382(Pt 1):27\u201332. https:\/\/doi.org\/10.1042\/BJ20040487","journal-title":"Biochem J"},{"issue":"5","key":"4218_CR66","doi-asserted-by":"publisher","first-page":"959","DOI":"10.1002\/jnr.10047","volume":"66","author":"M Dolinska","year":"2001","unstructured":"Dolinska M, Dybel A, Hilgier W, Zielinska M, Zablocka B, Buzanska L, Albrecht J (2001) Glutamine transport in C6 glioma cells: substrate specificity and modulation in a glutamine deprived culture medium. J Neurosci Res 66(5):959\u2013966. https:\/\/doi.org\/10.1002\/jnr.10047","journal-title":"J Neurosci Res"},{"issue":"7239","key":"4218_CR67","doi-asserted-by":"publisher","first-page":"762","DOI":"10.1038\/nature07823","volume":"458","author":"P Gao","year":"2009","unstructured":"Gao P, Tchernyshyov I, Chang TC, Lee YS, Kita K, Ochi T, Zeller KI, De Marzo AM, Van Eyk JE, Mendell JT, Dang CV (2009) c-Myc suppression of miR-23a\/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature 458(7239):762\u2013765. https:\/\/doi.org\/10.1038\/nature07823","journal-title":"Nature"},{"issue":"5","key":"4218_CR68","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1038\/onc.2012.635","volume":"33","author":"MR Reynolds","year":"2014","unstructured":"Reynolds MR, Lane AN, Robertson B, Kemp S, Liu Y, Hill BG, Dean DC, Clem BF (2014) Control of glutamine metabolism by the tumor suppressor Rb. Oncogene 33(5):556\u2013566. https:\/\/doi.org\/10.1038\/onc.2012.635","journal-title":"Oncogene"},{"issue":"7","key":"4218_CR69","doi-asserted-by":"publisher","first-page":"e356","DOI":"10.1038\/oncsis.2017.59","volume":"6","author":"J Dong","year":"2017","unstructured":"Dong J, Xiao D, Zhao Z, Ren P, Li C, Hu Y, Shi J, Su H, Wang L, Liu H, Li B, Gao P, Qing G (2017) Epigenetic silencing of microRNA-137 enhances ASCT2 expression and tumor glutamine metabolism. Oncogenesis 6(7):e356. https:\/\/doi.org\/10.1038\/oncsis.2017.59","journal-title":"Oncogenesis"},{"issue":"8","key":"4218_CR70","doi-asserted-by":"publisher","first-page":"1457","DOI":"10.1038\/s41418-017-0053-8","volume":"25","author":"M Luo","year":"2018","unstructured":"Luo M, Wu L, Zhang K, Wang H, Zhang T, Gutierrez L, O\u2019Connell D, Zhang P, Li Y, Gao T, Ren W, Yang Y (2018) miR-137 regulates ferroptosis by targeting glutamine transporter SLC1A5 in melanoma. Cell Death Differ 25(8):1457\u20131472. https:\/\/doi.org\/10.1038\/s41418-017-0053-8","journal-title":"Cell Death Differ"},{"issue":"3","key":"4218_CR71","doi-asserted-by":"publisher","first-page":"354","DOI":"10.1016\/j.ccell.2015.02.006","volume":"27","author":"YJ Jeon","year":"2015","unstructured":"Jeon YJ, Khelifa S, Ratnikov B, Scott DA, Feng Y, Parisi F, Ruller C, Lau E, Kim H, Brill LM, Jiang T, Rimm DL, Cardiff RD, Mills GB, Smith JW, Osterman AL, Kluger Y, Ronai ZA (2015) Regulation of glutamine carrier proteins by RNF5 determines breast cancer response to ER stress-inducing chemotherapies. Cancer Cell 27(3):354\u2013369. https:\/\/doi.org\/10.1016\/j.ccell.2015.02.006","journal-title":"Cancer Cell"},{"issue":"1","key":"4218_CR72","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1111\/j.1748-1716.2012.02412.x","volume":"205","author":"C Fanjul","year":"2012","unstructured":"Fanjul C, Barrenetxe J, Inigo C, Sakar Y, Ducroc R, Barber A, Lostao MP (2012) Leptin regulates sugar and amino acids transport in the human intestinal cell line Caco-2. Acta Physiol (Oxf) 205(1):82\u201391. https:\/\/doi.org\/10.1111\/j.1748-1716.2012.02412.x","journal-title":"Acta Physiol (Oxf)"},{"issue":"5","key":"4218_CR73","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1159\/000047812","volume":"11","author":"JW Ritchie","year":"2001","unstructured":"Ritchie JW, Baird FE, Christie GR, Stewart A, Low SY, Hundal HS, Taylor PM (2001) Mechanisms of glutamine transport in rat adipocytes and acute regulation by cell swelling. Cell Physiol Biochem 11(5):259\u2013270. https:\/\/doi.org\/10.1159\/000047812","journal-title":"Cell Physiol Biochem"},{"issue":"11","key":"4218_CR74","doi-asserted-by":"publisher","first-page":"3801","DOI":"10.1210\/en.2018-00574","volume":"159","author":"C Kang","year":"2018","unstructured":"Kang C, LeRoith D, Gallagher EJ (2018) Diabetes, obesity, and breast cancer. Endocrinology 159(11):3801\u20133812. https:\/\/doi.org\/10.1210\/en.2018-00574","journal-title":"Endocrinology"},{"issue":"1","key":"4218_CR75","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.taap.2012.09.011","volume":"265","author":"F Oppedisano","year":"2012","unstructured":"Oppedisano F, Catto M, Koutentis PA, Nicolotti O, Pochini L, Koyioni M, Introcaso A, Michaelidou SS, Carotti A, Indiveri C (2012) Inactivation of the glutamine\/amino acid transporter ASCT2 by 1,2,3-dithiazoles: proteoliposomes as a tool to gain insights in the molecular mechanism of action and of antitumor activity. Toxicol Appl Pharmacol 265(1):93\u2013102. https:\/\/doi.org\/10.1016\/j.taap.2012.09.011","journal-title":"Toxicol Appl Pharmacol"},{"issue":"Pt 3","key":"4218_CR76","doi-asserted-by":"publisher","first-page":"747","DOI":"10.1113\/jphysiol.2004.062521","volume":"557","author":"C Grewer","year":"2004","unstructured":"Grewer C, Grabsch E (2004) New inhibitors for the neutral amino acid transporter ASCT2 reveal its Na+-dependent anion leak. J Physiol 557(Pt 3):747\u2013759. https:\/\/doi.org\/10.1113\/jphysiol.2004.062521","journal-title":"J Physiol"},{"issue":"1","key":"4218_CR77","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1186\/s12885-018-4599-8","volume":"18","author":"M van Geldermalsen","year":"2018","unstructured":"van Geldermalsen M, Quek LE, Turner N, Freidman N, Pang A, Guan YF, Krycer JR, Ryan R, Wang Q, Holst J (2018) Benzylserine inhibits breast cancer cell growth by disrupting intracellular amino acid homeostasis and triggering amino acid response pathways. BMC Cancer 18(1):689. https:\/\/doi.org\/10.1186\/s12885-018-4599-8","journal-title":"BMC Cancer"},{"key":"4218_CR78","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.neuropharm.2017.08.010","volume":"126","author":"AC Foster","year":"2017","unstructured":"Foster AC, Rangel-Diaz N, Staubli U, Yang JY, Penjwini M, Viswanath V, Li YX (2017) Phenylglycine analogs are inhibitors of the neutral amino acid transporters ASCT1 and ASCT2 and enhance NMDA receptor-mediated LTP in rat visual cortex slices. Neuropharmacology 126:70\u201383. https:\/\/doi.org\/10.1016\/j.neuropharm.2017.08.010","journal-title":"Neuropharmacology"},{"issue":"4","key":"4218_CR79","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.1016\/j.bmc.2004.11.028","volume":"13","author":"CS Esslinger","year":"2005","unstructured":"Esslinger CS, Cybulski KA, Rhoderick JF (2005) N-gamma-aryl glutamine analogues as probes of the ASCT2 neutral amino acid transporter binding site. Bioorg Med Chem 13(4):1111\u20131118. https:\/\/doi.org\/10.1016\/j.bmc.2004.11.028","journal-title":"Bioorg Med Chem"},{"issue":"8","key":"4218_CR80","doi-asserted-by":"publisher","first-page":"1365","DOI":"10.1007\/s00726-017-2436-z","volume":"49","author":"M Chiu","year":"2017","unstructured":"Chiu M, Sabino C, Taurino G, Bianchi MG, Andreoli R, Giuliani N, Bussolati O (2017) GPNA inhibits the sodium-independent transport system L for neutral amino acids. Amino Acids 49(8):1365\u20131372. https:\/\/doi.org\/10.1007\/s00726-017-2436-z","journal-title":"Amino Acids"},{"key":"4218_CR81","doi-asserted-by":"publisher","first-page":"785","DOI":"10.3389\/fphar.2018.00785","volume":"9","author":"A Broer","year":"2018","unstructured":"Broer A, Fairweather S, Broer S (2018) Disruption of amino acid homeostasis by novel ASCT2 inhibitors involves multiple targets. Front Pharmacol 9:785. https:\/\/doi.org\/10.3389\/fphar.2018.00785","journal-title":"Front Pharmacol"},{"issue":"1","key":"4218_CR82","doi-asserted-by":"publisher","first-page":"C55","DOI":"10.1152\/ajpcell.00330.2006","volume":"293","author":"BC Fuchs","year":"2007","unstructured":"Fuchs BC, Finger RE, Onan MC, Bode BP (2007) ASCT2 silencing regulates mammalian target-of-rapamycin growth and survival signaling in human hepatoma cells. Am J Physiol Cell Physiol 293(1):C55-63. https:\/\/doi.org\/10.1152\/ajpcell.00330.2006","journal-title":"Am J Physiol Cell Physiol"},{"issue":"3","key":"4218_CR83","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1530\/ERC-12-0398","volume":"20","author":"S Kim","year":"2013","unstructured":"Kim S, Kim DH, Jung WH, Koo JS (2013) Expression of glutamine metabolism-related proteins according to molecular subtype of breast cancer. Endocr Relat Cancer 20(3):339\u2013348. https:\/\/doi.org\/10.1530\/ERC-12-0398","journal-title":"Endocr Relat Cancer"},{"issue":"1","key":"4218_CR84","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1002\/hep.29183","volume":"66","author":"P Liu","year":"2017","unstructured":"Liu P, Ge M, Hu J, Li X, Che L, Sun K, Cheng L, Huang Y, Pilo MG, Cigliano A, Pes GM, Pascale RM, Brozzetti S, Vidili G, Porcu A, Cossu A, Palmieri G, Sini MC, Ribback S, Dombrowski F, Tao J, Calvisi DF, Chen L, Chen X (2017) A functional mammalian target of rapamycin complex 1 signaling is indispensable for c-Myc-driven hepatocarcinogenesis. Hepatology 66(1):167\u2013181. https:\/\/doi.org\/10.1002\/hep.29183","journal-title":"Hepatology"},{"key":"4218_CR85","doi-asserted-by":"publisher","first-page":"16954","DOI":"10.1038\/srep16954","volume":"5","author":"Y Liu","year":"2015","unstructured":"Liu Y, Yang L, An H, Chang Y, Zhang W, Zhu Y, Xu L, Xu J (2015) High expression of Solute Carrier Family 1, member 5 (SLC1A5) is associated with poor prognosis in clear-cell renal cell carcinoma. Sci Rep 5:16954. https:\/\/doi.org\/10.1038\/srep16954","journal-title":"Sci Rep"},{"issue":"8","key":"4218_CR86","doi-asserted-by":"publisher","first-page":"2030","DOI":"10.1038\/bjc.2014.88","volume":"110","author":"K Shimizu","year":"2014","unstructured":"Shimizu K, Kaira K, Tomizawa Y, Sunaga N, Kawashima O, Oriuchi N, Tominaga H, Nagamori S, Kanai Y, Yamada M, Oyama T, Takeyoshi I (2014) ASC amino-acid transporter 2 (ASCT2) as a novel prognostic marker in non-small cell lung cancer. Br J Cancer 110(8):2030\u20132039. https:\/\/doi.org\/10.1038\/bjc.2014.88","journal-title":"Br J Cancer"},{"issue":"3","key":"4218_CR87","doi-asserted-by":"publisher","first-page":"1315","DOI":"10.1021\/acs.jproteome.6b00936","volume":"16","author":"P Kamarajan","year":"2017","unstructured":"Kamarajan P, Rajendiran TM, Kinchen J, Bermudez M, Danciu T, Kapila YL (2017) Head and neck squamous cell carcinoma metabolism draws on glutaminolysis, and stemness is specifically regulated by glutaminolysis via aldehyde dehydrogenase. J Proteome Res 16(3):1315\u20131326. https:\/\/doi.org\/10.1021\/acs.jproteome.6b00936","journal-title":"J Proteome Res"},{"issue":"1","key":"4218_CR88","doi-asserted-by":"publisher","first-page":"4995","DOI":"10.1038\/s41598-019-41523-4","volume":"9","author":"J Yang","year":"2019","unstructured":"Yang J, Guo Y, Seo W, Zhang R, Lu C, Wang Y, Luo L, Paul B, Yan W, Saxena D, Li X (2019) Targeting cellular metabolism to reduce head and neck cancer growth. Sci Rep 9(1):4995. https:\/\/doi.org\/10.1038\/s41598-019-41523-4","journal-title":"Sci Rep"},{"issue":"1","key":"4218_CR89","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.canlet.2016.07.020","volume":"381","author":"H Lu","year":"2016","unstructured":"Lu H, Li X, Lu Y, Qiu S, Fan Z (2016) ASCT2 (SLC1A5) is an EGFR-associated protein that can be co-targeted by cetuximab to sensitize cancer cells to ROS-induced apoptosis. Cancer Lett 381(1):23\u201330. https:\/\/doi.org\/10.1016\/j.canlet.2016.07.020","journal-title":"Cancer Lett"},{"key":"4218_CR90","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.canlet.2017.08.012","volume":"408","author":"X Tao","year":"2017","unstructured":"Tao X, Lu Y, Qiu S, Wang Y, Qin J, Fan Z (2017) AP1G1 is involved in cetuximab-mediated downregulation of ASCT2-EGFR complex and sensitization of human head and neck squamous cell carcinoma cells to ROS-induced apoptosis. Cancer Lett 408:33\u201342. https:\/\/doi.org\/10.1016\/j.canlet.2017.08.012","journal-title":"Cancer Lett"},{"issue":"2","key":"4218_CR91","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1016\/j.tibs.2013.12.004","volume":"39","author":"KL Bryant","year":"2014","unstructured":"Bryant KL, Mancias JD, Kimmelman AC, Der CJ (2014) KRAS: feeding pancreatic cancer proliferation. Trends Biochem Sci 39(2):91\u2013100. https:\/\/doi.org\/10.1016\/j.tibs.2013.12.004","journal-title":"Trends Biochem Sci"},{"issue":"3","key":"4218_CR92","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.cllc.2012.09.007","volume":"14","author":"N Karachaliou","year":"2013","unstructured":"Karachaliou N, Mayo C, Costa C, Magri I, Gimenez-Capitan A, Molina-Vila MA, Rosell R (2013) KRAS mutations in lung cancer. Clin Lung Cancer 14(3):205\u2013214. https:\/\/doi.org\/10.1016\/j.cllc.2012.09.007","journal-title":"Clin Lung Cancer"},{"issue":"2","key":"4218_CR93","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1016\/j.lungcan.2013.11.010","volume":"83","author":"MK Maus","year":"2014","unstructured":"Maus MK, Grimminger PP, Mack PC, Astrow SH, Stephens C, Zeger G, Hsiang J, Brabender J, Friedrich M, Alakus H, Holscher AH, Lara P, Danenberg KD, Lenz HJ, Gandara DR (2014) KRAS mutations in non-small-cell lung cancer and colorectal cancer: implications for EGFR-targeted therapies. Lung Cancer 83(2):163\u2013167. https:\/\/doi.org\/10.1016\/j.lungcan.2013.11.010","journal-title":"Lung Cancer"},{"issue":"9","key":"4218_CR94","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nrclinonc.2009.111","volume":"6","author":"N Normanno","year":"2009","unstructured":"Normanno N, Tejpar S, Morgillo F, De Luca A, Van Cutsem E, Ciardiello F (2009) Implications for KRAS status and EGFR-targeted therapies in metastatic CRC. Nat Rev Clin Oncol 6(9):519\u2013527. https:\/\/doi.org\/10.1038\/nrclinonc.2009.111","journal-title":"Nat Rev Clin Oncol"},{"issue":"7","key":"4218_CR95","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41591-018-0111-x","volume":"24","author":"TT Mai","year":"2018","unstructured":"Mai TT, Lito P (2018) A treatment strategy for KRAS-driven tumors. Nat Med 24(7):902\u2013904. https:\/\/doi.org\/10.1038\/s41591-018-0111-x","journal-title":"Nat Med"},{"issue":"12","key":"4218_CR96","doi-asserted-by":"publisher","first-page":"e0168907","DOI":"10.1371\/journal.pone.0168907","volume":"11","author":"HW Sun","year":"2016","unstructured":"Sun HW, Yu XJ, Wu WC, Chen J, Shi M, Zheng L, Xu J (2016) GLUT1 and ASCT2 as predictors for prognosis of hepatocellular carcinoma. PLoS ONE 11(12):e0168907. https:\/\/doi.org\/10.1371\/journal.pone.0168907","journal-title":"PLoS ONE"},{"issue":"6","key":"4218_CR97","doi-asserted-by":"publisher","first-page":"e0179363","DOI":"10.1371\/journal.pone.0179363","volume":"12","author":"K Bjersand","year":"2017","unstructured":"Bjersand K, Seidal T, Sundstrom-Poromaa I, Akerud H, Skirnisdottir I (2017) The clinical and prognostic correlation of HRNPM and SLC1A5 in pathogenesis and prognosis in epithelial ovarian cancer. PLoS ONE 12(6):e0179363. https:\/\/doi.org\/10.1371\/journal.pone.0179363","journal-title":"PLoS ONE"},{"issue":"10","key":"4218_CR98","doi-asserted-by":"publisher","first-page":"2506","DOI":"10.1038\/bjc.2014.178","volume":"110","author":"M Toyoda","year":"2014","unstructured":"Toyoda M, Kaira K, Ohshima Y, Ishioka NS, Shino M, Sakakura K, Takayasu Y, Takahashi K, Tominaga H, Oriuchi N, Nagamori S, Kanai Y, Oyama T, Chikamatsu K (2014) Prognostic significance of amino-acid transporter expression (LAT1, ASCT2, and xCT) in surgically resected tongue cancer. Br J Cancer 110(10):2506\u20132513. https:\/\/doi.org\/10.1038\/bjc.2014.178","journal-title":"Br J Cancer"},{"issue":"25","key":"4218_CR99","doi-asserted-by":"publisher","first-page":"13194","DOI":"10.1074\/jbc.M115.700534","volume":"291","author":"A Broer","year":"2016","unstructured":"Broer A, Rahimi F, Broer S (2016) Deletion of amino acid transporter ASCT2 (SLC1A5) reveals an essential role for transporters SNAT1 (SLC38A1) and SNAT2 (SLC38A2) to sustain glutaminolysis in cancer cells. J Biol Chem 291(25):13194\u201313205. https:\/\/doi.org\/10.1074\/jbc.M115.700534","journal-title":"J Biol Chem"},{"issue":"8","key":"4218_CR100","doi-asserted-by":"publisher","first-page":"2877","DOI":"10.1074\/jbc.RA117.001342","volume":"293","author":"Y Cormerais","year":"2018","unstructured":"Cormerais Y, Massard PA, Vucetic M, Giuliano S, Tambutte E, Durivault J, Vial V, Endou H, Wempe MF, Parks SK, Pouyssegur J (2018) The glutamine transporter ASCT2 (SLC1A5) promotes tumor growth independently of the amino acid transporter LAT1 (SLC7A5). J Biol Chem 293(8):2877\u20132887. https:\/\/doi.org\/10.1074\/jbc.RA117.001342","journal-title":"J Biol Chem"},{"issue":"3","key":"4218_CR101","first-page":"113","volume":"52","author":"Y Hashimoto","year":"2004","unstructured":"Hashimoto Y, Sadamoto Y, Konno A, Kon Y, Iwanaga T (2004) Distribution of neutral amino acid transporter ASCT 1 in the non-neuronal tissues of mice. Jpn J Vet Res 52(3):113\u2013124","journal-title":"Jpn J Vet Res"}],"container-title":["Cancer Chemotherapy and Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00280-020-04218-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00280-020-04218-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,3,10]],"date-time":"2021-03-10T16:11:51Z","timestamp":1615392711000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00280-020-04218-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,1,19]]},"references-count":101,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["4218"],"URL":"https:\/\/doi.org\/10.1007\/s00280-020-04218-6","relation":{},"ISSN":["0344-5704","1432-0843"],"issn-type":[{"value":"0344-5704","type":"print"},{"value":"1432-0843","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,1,19]]},"assertion":[{"value":"30 September 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 December 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 January 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare that they have no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}